121 - 140 of 165 Results
Basser Scientific Symposium 2025
Scientific Symposium Day 1 Agenda
Basser Summer Scholars Internship Program
This internship was created to expand the pipeline of candidates with experientially diverse backgrounds pursuing a career in genetic counseling, clinical genetics, and basic science.
External Research Grant Program
The Basser Center External Research Grant Program focuses on projects that have the potential to advance the care of individuals living with BRCA1 or BRCA2 mutations.
Scientific Symposium Day 2 Agenda
Scientific Symposium 2025 Registration
Young Leadership Council Profile: Kevin Kucharski
In this month’s profile, get to know Basser Young Leadership Council member Kevin Kucharski, a BRCA2 mutation carrier and medical student.
Required Authorized Signatures: External Grants
2025 Scientific Symposium Abstract Submissions
Visitor Information
Accreditation Information
Internal Research Grant Program
The Basser Center Internal Research Grant Program for Penn Investigators focuses on projects that have the potential to advance the care of individuals living with BRCA1 or BRCA2 mutations.
Staying Positive After Testing Positive
Hilary shares how her journey as a BRCA2 mutation carrier has profoundly shaped her life and her decision to undergo preventative surgery.
Required Authorized Signatures: Internal Grants
Abstract Submission Confirmation
Basser Center for BRCA Postdoctoral Fellowship Program
The Basser Postdoctoral Fellowship Program (BPFP) will provide support for one postdoctoral fellows for up to three years. Our goal is to train investigators across a spectrum of disciplines, including basic and translational science, implementation and behavioral science, preventive medicine, bioinformatics, and clinical trials.
Grants Program
#PhiladelphiaPhil Celebrates 100 Years with the Eagles & Other Exciting News
Phil Basser, patriarch of the Basser family, has recently made it into the news for his legendary love of the Philadelphia Eagles.
2025 Scientific Symposium Poster Session
New PARP Inhibitor Trial for BRCA1/2 and PALB2-Related Pancreatic Cancer
A phase II clinical trial that began in August of 2017, “A Phase 2, Open Label Study of Rucaparib in Patients With Advanced Pancreatic Cancer and a Known Deleterious Germline or Somatic BRCA or PALB2 Mutation,” is enrolling patients at the Hospital of the University of Pennsylvania.